Drug Trials Snapshot: CIBINQO
CIBINQO is a Janus Kinase (JAK) inhibitor that is indicated for the treatment of adults with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 7, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Atopic Dermatitis Tied to Higher Venous Thromboembolism Risk
WEDNESDAY, May 31, 2023 -- Atopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study published online May 31 in JAMA Dermatology.
Tai-Li Chen, M.D., from Taipei Veterans General... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2023 Category: Pharmaceuticals Source Type: news
Enthesitis Linked to Dupilumab Use for Atopic Dermatitis Enthesitis Linked to Dupilumab Use for Atopic Dermatitis
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how enthesitis develops.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 31, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
JAK-Inhibitor Safety in Adolescents With AD Reported JAK-Inhibitor Safety in Adolescents With AD Reported
Longer-term safety data on two JAK inhibitors approved for treating atopic dermatitis in adolescents are accumulating.MDedge News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - May 30, 2023 Category: Pediatrics Tags: Dermatology News Source Type: news
Mindfulness Improves Life Quality in Patients With AD Mindfulness Improves Life Quality in Patients With AD
Patients with atopic dermatitis do better after taking part in online mindfulness and self-compassion training, researchers in Japan report.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 23, 2023 Category: Psychiatry Tags: Dermatology News Source Type: news
Allergies from At-Home Gel and Acrylic Manicures Are On the Rise
Hardly anyone uses normal nail polish anymore, it seems. Now, gel and acrylic manicures are the thing—and you don’t even have to go to a salon to get them.
Gel and acrylic manis appeal to many because they can last for three weeks (or even longer) without chipping. In the last few years, the UV lamps required to harden or “cure” more chip-proof polishes have gone from specialty salon tools to household appliances, spurred initially by women seeking salon-style nails during lockdown. There’s a booming market for chemically-hardening products like powders, gels, and putties, often promoted by h...
Source: TIME: Health - May 18, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Public Health Source Type: news
Two Biologics Evaluated for Facial, Hand, Foot Dermatitis Two Biologics Evaluated for Facial, Hand, Foot Dermatitis
' Lebrikizumab was efficacious in clearing and improving facial and hand dermatitis, burdensome and difficult-to-treat areas, in most patients, ' Dr Jenny Murase said, in reporting results at RAD 2023.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 16, 2023 Category: Internal Medicine Tags: Dermatology News Source Type: news
Nasal Colonization With Staph Bacteria Linked to Acute Radiation Dermatitis
FRIDAY, May 12, 2023 -- Nasal colonization with Staphylococcus aureus (SA) before radiation therapy (RT) is associated with acute radiation dermatitis (ARD) severity, and bacterial decolonization (BD) is effective for ARD prophylaxis, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 12, 2023 Category: Pharmaceuticals Source Type: news
Mindfulness, Self-Compassion Training Improves QOL in Eczema
WEDNESDAY, May 10, 2023 -- A mindfulness and self-compassion training intervention is effective for improving quality of life (QOL) among adults with atopic dermatitis, according to a study published online May 10 in JAMA Dermatology.
Sanae... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 10, 2023 Category: Pharmaceuticals Source Type: news
New Hope Against Painful Skin Issues Caused by Radiation Therapy
Two new studies suggest that a simple antibacterial treatment may be the solution for acute radiation dermatitis. (Source: WebMD Health)
Source: WebMD Health - May 8, 2023 Category: Consumer Health News Source Type: news
Bacterial Decolonization Reduces Severity of Acute Radiation Dermatitis
(MedPage Today) -- While staphylococcus aureus may play a role in the development of acute radiation dermatitis (ARD) in patients undergoing radiation therapy, bacterial decolonization (BD) can decrease the severity of the condition, particularly... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 4, 2023 Category: Dermatology Source Type: news
Beware the Hidden Allergens in Nutritional Supplements
An expert reviewed allergens that are found in popular supplements and that have been implicated in allergic reactions, including contact dermatitis. (Source: WebMD Health)
Source: WebMD Health - May 2, 2023 Category: Consumer Health News Source Type: news
Beware the Hidden Allergens in Nutritional Supplements Beware the Hidden Allergens in Nutritional Supplements
An expert reviewed allergens that are found in popular supplements and that have been implicated in allergic reactions, including contact dermatitis.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 1, 2023 Category: Internal Medicine Tags: Dermatology News Source Type: news
Implications of atopic dermatitis on the quality of life of 6-11 years old children and caregivers (PEDI-BURDEN) - Neri I, Galli E, Baiardini I, Picozza M, Rossi AB, Matruglio P, Moretti D, Cipriani F.
This study pres... (Source: SafetyLit)
Source: SafetyLit - April 22, 2023 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
FDA to Review Roflumilast Foam for Seborrheic Dermatitis FDA to Review Roflumilast Foam for Seborrheic Dermatitis
If approved, the once-daily foam would be the first topical drug with a new mechanism of action for seborrheic dermatitis in more than two decades.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 19, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
